Monoclonal Antibody Infusion for Cancer Therapy
Monoclonal antibody infusions such as rituximab are biotechnologically produced proteins that target specific cancer cells. These immunological products are directly involved in regulating immune processes, making them classifiable under tariff item 3002.90.00. They are prepared for therapeutic use in oncology.
Import Duty Rates by Country of Origin
| Origin Country | MFN Tariff | Surtaxes | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇺🇸United States | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If the antibody is presented as a specific product for therapeutic use
Subheading 3002.14 covers immunological products for therapeutic use, distinct from the 'other' category.
If packaged in measured doses for retail sale
Medicaments in measured doses fall under heading 30.04.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right tariff item — and can price the duty on it in the same conversation.
Import Tips & Compliance
• Ensure the product has a valid DIN from Health Canada
• Provide documentation of the biotechnological manufacturing process
• Check if a controlled substances permit is needed for certain active ingredients
Related Products under Tariff item 3002.90.00
Anticoagulated Whole Human Blood Units
Anticoagulated whole human blood units are collected from donors and treated with CPD or CPDA-1 to prevent clotting. These units are stored in PVC bags for emergency transfusions. As unmodified whole human blood for therapeutic use, they fall under tariff item 3002.90.00.
Anti-Hemophilic Factor VIII Concentrate
A lyophilized concentrate of coagulation Factor VIII derived from human plasma, used therapeutically for hemophilia A treatment. As a blood fraction prepared for therapeutic uses, it falls under tariff item 3002.90.00 as 'Other' within the heading for human blood and immunological products.
Aspergillopepsin Antifungal Ferment
Purified aspergillopepsin ferment derived from Aspergillus molds, formulated for therapeutic antifungal applications in human patients. This product is a microbial culture-derived ferment prepared for therapeutic use, excluding yeasts, and falls under tariff item 3002.90.00 as 'Other' within the heading for immunological products and similar goods.
Azelastine Hydrochloride Nasal Spray
Azelastine hydrochloride nasal spray is an antihistamine used to relieve seasonal allergic rhinitis. It is an antiallergenic preparation that targets nasal mucosa allergies. Despite its therapeutic use, it is not an immunological product and is incorrectly listed under this tariff item.
Bepotastine Besilate Eye Drops
Bepotastine besilate eye drops are a topical antihistamine for ocular allergies and conjunctivitis. They are antiallergenic preparations targeting eye-specific histamine blockade. These are not immunological products and should not be classified under tariff item 3002.90.00.
Bilastine 20mg Tablets
Bilastine 20mg tablets are a non-sedating antihistamine for allergic rhinitis and urticaria. They require food co-administration for absorption. As an antiallergenic preparation, they are not immunological products and are incorrectly listed under tariff item 3002.90.00.